Cargando…
Public engagement and clinical trials : new models and disruptive technologies : workshop summary /
"Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognit...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores Corporativos: | , |
| Otros Autores: | , , |
| Formato: | Electrónico Congresos, conferencias eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
2011.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn769188485 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 111205s2011 dcua ob 100 0 eng d | ||
| 040 | |a E7B |b eng |e pn |c E7B |d IDEBK |d N$T |d MMU |d YDXCP |d TPH |d OCLCQ |d CDX |d UCNAP |d ZMC |d OCLCQ |d OCLCA |d OCLCF |d NLGGC |d COO |d OCLCQ |d VT2 |d OCLCQ |d AGLDB |d TOA |d MOR |d OCLCO |d PIFAG |d OCLCQ |d OCLCA |d BUF |d OCLCO |d STF |d VNS |d WRM |d VTS |d NRAMU |d EZ9 |d ICG |d MERER |d REC |d AU@ |d OCLCQ |d OCLCO |d LVT |d M8D |d OCLCQ |d OCLCO |d OCLCA |d UKCRE |d AJS |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 016 | 7 | |a 101582836 |2 DNLM | |
| 016 | 7 | |a 016066521 |2 Uk | |
| 019 | |a 760055026 |a 772459094 |a 971092635 |a 988460703 |a 991919289 |a 1037929686 |a 1038664408 |a 1045551101 |a 1047527785 |a 1058168116 |a 1153534888 | ||
| 020 | |a 9780309219297 |q (e-book) | ||
| 020 | |a 0309219299 |q (e-book) | ||
| 020 | |a 9780309219303 |q (electronic bk.) | ||
| 020 | |a 0309219302 |q (electronic bk.) | ||
| 020 | |z 0309219299 | ||
| 029 | 1 | |a AU@ |b 000053277267 | |
| 029 | 1 | |a DEBBG |b BV043151973 | |
| 029 | 1 | |a DEBBG |b BV044109323 | |
| 029 | 1 | |a DEBSZ |b 421509481 | |
| 029 | 1 | |a GBVCP |b 803748361 | |
| 029 | 1 | |a NZ1 |b 14257074 | |
| 029 | 1 | |a AU@ |b 000068567689 | |
| 035 | |a (OCoLC)769188485 |z (OCoLC)760055026 |z (OCoLC)772459094 |z (OCoLC)971092635 |z (OCoLC)988460703 |z (OCoLC)991919289 |z (OCoLC)1037929686 |z (OCoLC)1038664408 |z (OCoLC)1045551101 |z (OCoLC)1047527785 |z (OCoLC)1058168116 |z (OCoLC)1153534888 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a R853.C55 |b P83 2011eb | |
| 060 | 4 | |a QV 771 | |
| 072 | 7 | |a MED |x 047000 |2 bisacsh | |
| 082 | 0 | 4 | |a 610.724 |2 23 |
| 049 | |a UAMI | ||
| 111 | 2 | |a Public Engagement and Clinical Trials: New Models and Disruptive Technologies |d (2011 : |c Mount Sinai School of Medicine) | |
| 245 | 1 | 0 | |a Public engagement and clinical trials : |b new models and disruptive technologies : workshop summary / |c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c 2011. | ||
| 300 | |a 1 online resource (xvi, 124 pages) : |b color illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (pages 85-87). | ||
| 520 | |a "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description. | ||
| 505 | 0 | 0 | |t Introduction -- |t Framing the problem -- |t Recruitment challenges in clinical trials for different diseases and conditions -- |t Models for public health engagement -- |t The media -- |t Novel clinical trial designs -- |t The health system's structure and culture -- |t Toward a patient-centered strategy for clinical trials. |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Clinical trials. | |
| 650 | 0 | |a Patient participation. | |
| 650 | 0 | |a Patient education. | |
| 650 | 1 | 2 | |a Clinical Trials as Topic |
| 650 | 1 | 2 | |a Patient Participation |
| 650 | 2 | 2 | |a Drug Evaluation |
| 650 | 2 | 2 | |a Patient Education as Topic |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Études cliniques. | |
| 650 | 6 | |a Participation des patients. | |
| 650 | 6 | |a Éducation des patients. | |
| 650 | 7 | |a MEDICAL |x Laboratory Medicine. |2 bisacsh | |
| 650 | 7 | |a Patient participation |2 fast | |
| 650 | 7 | |a Patient education |2 fast | |
| 650 | 7 | |a Clinical trials |2 fast | |
| 655 | 4 | |a Electronic resource. | |
| 700 | 1 | |a Weisfeld, Victoria D. | |
| 700 | 1 | |a English, Rebecca A. | |
| 700 | 1 | |a Claiborne, Anne B. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 776 | 0 | 8 | |i Print version: |t Public Engagement and Clinical Trials. |d Washington, D.C. : National Academies Press, ©2011 |z 9780309219297 |w (OCoLC)767570602 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 |z Texto completo |
| 938 | |a Coutts Information Services |b COUT |n 19873040 | ||
| 938 | |a ebrary |b EBRY |n ebr10506513 | ||
| 938 | |a EBSCOhost |b EBSC |n 400080 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 331196 | ||
| 938 | |a YBP Library Services |b YANK |n 7365280 | ||
| 994 | |a 92 |b IZTAP | ||